Library Preparation News and Research

RSS
New benchtop robotic workstation simplifies next-generation sequencing workflows

New benchtop robotic workstation simplifies next-generation sequencing workflows

IntegenX receives DTRA contract to develop ISS system for rapid detection of emerging pathogens

IntegenX receives DTRA contract to develop ISS system for rapid detection of emerging pathogens

GATC Biotech to apply Illumina's HiSeq 2000 for human genome analysis

GATC Biotech to apply Illumina's HiSeq 2000 for human genome analysis

NEB introduces NEBNext Quick DNA Sample Prep Reagent Set 2, Master Mix Set 2

NEB introduces NEBNext Quick DNA Sample Prep Reagent Set 2, Master Mix Set 2

DNASTAR, Scarab Genomics announce launch of DNA and RNA sequencing services business

DNASTAR, Scarab Genomics announce launch of DNA and RNA sequencing services business

Fluidigm releases protocol for Access Array System for sequencing amplicon libraries

Fluidigm releases protocol for Access Array System for sequencing amplicon libraries

Finding right balance between high-throughput sequencing and related bioinformatics analysis

Finding right balance between high-throughput sequencing and related bioinformatics analysis

Microchip Biotechnologies renamed as IntegenX

Microchip Biotechnologies renamed as IntegenX

Fluidigm releases amplicon tagging protocol for Illumina GA II next-generation sequencer

Fluidigm releases amplicon tagging protocol for Illumina GA II next-generation sequencer

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.